Clinical trial

Arterial Spin Labeling (ASL) MRI for Cognitive Decline

NCT01727622

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention FDG-PET Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention ASL-MRI Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Lumbar Puncture Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Arterial Spin Labeling (ASL) MRI for Cognitive Decline

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2012-08-01

PhaseN/A

Conditions

Mild Cognitive Impairmentunresolved

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Interventions

FDG-PETDRUG

ASL-MRIOTHER

Lumbar PuncturePROCEDURE

Sponsors & collaborators

University of Pennsylvanialead sponsor

National Institute on Aging (NIA)collaborator

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01727622 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.